Current status of anti-angiogenesis therapy for non-small cell lung cancer
10.11904/j.issn.1002-3070.2017.05.017
- VernacularTitle:非小细胞肺癌抗血管生成治疗研究现状
- Author:
Xin DAI
1
Author Information
1. 哈尔滨医科大学附属第一医院肿瘤科
- Keywords:
Anti-angiogenesis;
Non-small cell lung cancer;
VEGF;
TKI
- From:
Practical Oncology Journal
2017;31(5):472-476
- CountryChina
- Language:Chinese
-
Abstract:
Angiogenesis is the physiological process of generating new blood vessels from existing net-works.In the tumor microenvironment,the dynamic balance of a growing tumor facilitates the transition to persis-tent angiogenesis.Antiangiogenic drugs have been used in a variety of solid tumors,including lung cancers,by re-sisting tumor angiogenesis and inhibiting tumor growth,since human recognized its ability.In this paper,recent re-search status of tumor angiogenesis and non-small cell lung cancer anti-angiogenesis are reviewed in details.
